THERAPEUTIC CLASS

Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR‑TKI treatment in advanced NSCLC

---

Previous studies have suggested that a variety of tumor driver genetic alterations affected the treatment efficacy of chemotherapy and epidermal growth factor receptor (EGFR)‑tyrosine kinase inhibitors (TKIs) in advanced non‑small cell lung cancer (NSCLC). The present study aimed to investigate the association between the tumor genetic alteration landscape and the treatment outcome of first‑line chemotherapy and EGFR‑TKIs in advanced NSCLC

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oncology
Docetaxel
Carboplatin
Cisplatin
Fonkogem

Specific Detail Info

ONCOLOGY LETTERS 19: 3859-3870, 2020

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment